Highest-materiality recent filing
Fortive shareholders elect all 8 director nominees, approve say-on-pay, ratify EY as auditor
All eight director nominees elected; Olumide Soroye highest with 281.2M votes for, Jeannine Sargent lowest with 268.8M.
Fortive issues $1.1B in notes to refinance maturing debt and for general corporate purposes
$600M of 4.750% notes due 2031 and $500M of 5.250% notes due 2036 issued May 14, 2026.
Fortive Q1 2026 adjusted EPS $0.70 beats; revenue up 7.7%; buys back $500M shares
GAAP diluted EPS $0.44 (+33.3% YoY); adjusted diluted EPS $0.70 (+25.4% YoY).
Fortive enters $2.0B revolving credit facility due 2031, replacing 2022 facility
New $2.0B 5-year revolving credit facility matures March 17, 2031; no borrowings at closing.
Fortive Q4 adj EPS $0.90 beats; FY 2025 adj EPS $2.71 above high-end; guides FY 2026 $2.90-$3.00
Q4 revenue $1.12B (+4.6% reported, +3.3% core); adj EBITDA margin 31.9% (+90 bps YoY).
Fortive Q3 adj. EPS $0.68 beats, raises FY25 guidance to $2.63-2.67, $1B buyback
Revenue $1.03B (core +1.9%), GAAP EPS $0.35, adj. EPS $0.68 (+15.3% YoY).
Fortive CPO Stacey Walker to retire effective Jan 2, 2026
Stacey Walker, SVP and Chief People Officer, notified Fortive of her retirement on Oct 13, 2025.
Fortive Q2 adjusted EPS $0.58 at high end of guidance; completes Ralliant spin-off
Continuing ops revenue $1.016B, down 0.4% YoY; core revenue decline 0.7%.
Fortive spins off Ralliant (1:3 ratio), names new CEO; Q2 revenue seen flat to slightly down
Spin-off effective June 28, 2025; shareholders received 1 RAL share per 3 FTV shares; about 113M RAL shares distributed.
Hosted Investor Day on June 10, 2025, discussing separation of Precision Technologies segment into Ralliant.
All nine director nominees elected with >95% support; top vote-getter James A. Lico received 307.3M for.
Fortive blackout period on stock fund from June 27 to July 6 due to Ralliant spin-off
Blackout on Fortive Stock Fund due to Ralliant separation; participants cannot transfer in/out from June 27 to July 6.
Ralliant, Fortive subsidiary, enters $2.05B credit facility contingent on spin-off
$700M three-year and $600M eighteen-month senior unsecured delayed draw term loans, plus $750M revolver.
Fortive Q1 adjusted EPS $0.85 in line; guides FY25 adj. EPS $3.80-$4.00; Ralliant spin targeted Q2
Q1 GAAP EPS $0.50, adjusted EPS $0.85; revenue $1.47B (-3% YoY); adjusted operating margin 25.3% (+20bps YoY).
Fortive appoints Mark Okerstrom as CFO effective March 24, 2025; McLaughlin retires
Mark Okerstrom named SVP & CFO, effective March 24, 2025, succeeding Charles McLaughlin who retires but remains through Dec 2025.
Fortive appoints Gregory J. Moore to Board, increasing size to 10 members
Board size increased from 9 to 10; Dr. Moore appointed effective Feb 26, 2025 through 2025 Annual Meeting.
Fortive Q4 adjusted EPS $1.17 beats; record cash flow; spin-off on track for early Q3'25
Q4 revenue $1.62B (+2% YoY); GAAP EPS $0.60, adjusted EPS $1.17 (+19% YoY).
Fortive Board Chair Alan G. Spoon to retire; Sharmistha Dubey named new Chair
Alan G. Spoon will not stand for re-election at 2025 Annual Meeting (June 3, 2025) and will retire from Board effective that date.
Fortive urges shareholders to reject TRC Capital mini-tender offer at $75/sh, 4.93% below market
TRC Capital offers to buy up to 1.5M Fortive shares (0.44% of outstanding) at $75.00/sh, a 4.93% discount to Dec 6 close.
Fortive Q3 revenue $1.54B (+3% YoY), adj. EPS $0.97 (+14%), raises FY outlook
GAAP diluted EPS $0.63; adjusted diluted EPS $0.97 (up 14% YoY), above Q3 guidance high-end.
Fortive to spin off Precision Technologies into NewCo; CEO Lico to retire, Soroye to take over
Plans tax-free spin-off of Precision Technologies segment into a separate public company, targeting Q4 2025 completion.
Fortive Q2 adj EPS $0.93 at high-end; narrows FY2024 outlook to $3.80-$3.86
Q2 revenue $1.55B (+2% YoY), core flat; GAAP EPS $0.55, adj EPS $0.93 (high-end guidance).
Fortive shareholders elect all 9 directors, approve say-on-pay, reject director comp proposal
All nine director nominees elected; Sharmistha Dubey received highest against votes (~31M).
Fortive Q1 adjusted EPS $0.83, revenue $1.52B both beat; raises FY outlook
GAAP diluted EPS $0.58 (+18% YoY); adjusted diluted EPS $0.83 (+11% YoY). Revenue $1.52B (+4%, core +3%).
Fortive issues €1.2B in 3.700% notes to refinance acquisition-related debt
Issued €500M 3.700% notes due Feb 2026 and €700M 3.700% notes due Aug 2029.
Fortive Q4 adj EPS $0.98, revenue $1.58B; guides FY24 adj EPS $3.73-$3.85
Q4 GAAP diluted EPS $0.75 (+17% YoY); adjusted diluted EPS $0.98 (+11% YoY).
Fortive enters $1.3B delayed-draw term loan facility due Dec 2024
$1.3B unsecured delayed-draw term loan; no borrowings on closing Dec 7, 2023.
Fortive reports Q3 revenue $1.49B (+2.6% YoY); adj. EPS $0.85 (+8%); narrows FY2023 outlook
Q3 revenue $1.49B, up 2.6% YoY (core +2.5%); operating margin expanded 220bps to 20%.
Fortive Q2 beats with record margins; raises full-year EPS outlook
Revenue $1.53B (+4.3% YoY, core +5.5%); GAAP EPS $0.59 (+23%), adj. EPS $0.85 (+9%).
Fortive shareholders elect all nine directors, approve say-on-pay at 2023 annual meeting
All nine director nominees elected with majority support; Alan G. Spoon received 286.5M for vs 30.5M against.
Fortive Q1 revenue $1.46B (+6% YoY), adj EPS $0.75 (+7%); raises FY guidance low end
Q1 revenue $1.46B (+6% YoY, +9% core); GAAP EPS $0.49, adj EPS $0.75 (+7%).
Fortive adopts policy requiring shareholder vote for executive severance above 2.99x base+bonus
Policy adopted Feb 27, 2023, effective immediately, applies to all Section 16 officers.
Fortive Q4 revenue up 11% to $1.53B; adj EPS $0.88; guides 2023 adj EPS $3.25-$3.40
Q4 Revenue $1.53B (+11% YoY, core +14%); GAAP EPS $0.64, Adjusted EPS $0.88 (+11%)
Fortive appoints Eric Branderiz to Board; board size increases to nine
Board increased from eight to nine members, effective January 1, 2023.
Fortive amends bylaws to adopt universal proxy rule requirements
Board adopted amended and restated bylaws effective November 3, 2022.
Fortive Q3 revenue $1.46B (+12%), adj. EPS $0.79; raises full-year adj. EPS guidance to $3.10-$3.13
Q3 revenue $1.46B (+12% YoY); core revenue up 12%; GAAP net earnings $190M.
Fortive enters $2.0B revolver and $1.0B term loan agreements; extends maturity to 2027
$2.0B unsecured revolver matures Oct 18, 2027; includes two one-year extension options and a $1.0B increase option.
Fortive Q2 revenue up 11% to $1.46B, raises full-year adjusted EPS guidance to $3.07-$3.13
Q2 revenue $1.46B (+11% YoY), core growth 9%; GAAP EPS $0.48, adjusted EPS $0.78 (+18% YoY).
Fortive shareholders approve supermajority voting elimination, elect directors at annual meeting
Amendment to Restated Certificate of Incorporation eliminating supermajority voting requirements approved and effective June 7, 2022.
Fortive Q1 revenue $1.4B, adj EPS $0.70; raises FY2022 adj EPS guidance to $3.04-$3.13
Q1 revenue $1.4B, up 9.3% YoY; core revenue growth 5.3%.
Fortive Q4 adj. EPS $0.79 (+13% YoY); FY22 adj. EPS guidance $3.00-$3.13
Q4 revenue $1.37B (+3.8% YoY); core revenue +1.0% amid supply chain and COVID challenges.
Fortive appoints Wright Lassiter III to Compensation Committee, effective Jan 25, 2022
Wright Lassiter III joined Fortive Board on Jan 1, 2022; now assigned to Compensation Committee.
Fortive enters $1B 364-day term loan facility, draws full amount
$1 billion delayed-draw term loan fully drawn at closing on Dec 16, 2021.
Fortive appoints Wright Lassiter III to Board, expands to nine members
Board size increased to nine members effective January 1, 2022.
Fortive Q3 revenue $1.3B (+12% YoY); adj. EPS $0.66; raises FY adjusted EPS guidance
Revenue increased 12% YoY to $1.3B; core revenue up 9.1%.
Barbara Hulit will retire as President and CEO of Advanced Healthcare Solutions segment effective December 31, 2021.
Fortive Q2 revenue $1.3B (+26.7%), adj. EPS $0.66; raises 2021 guidance
Diluted EPS from continuing ops $0.48; adjusted diluted EPS $0.66, up 53% YoY.
Fortive to acquire ServiceChannel for ~$1.2B; Q2 prelim revenue growth ~25% YoY
Acquires ServiceChannel for $1.2B in cash; expected to close Q3 2021.
Fortive eliminates preferred stock certificate after full conversion
Filed Certificate of Elimination with Delaware Secretary on July 6, 2021.
On March 4, 2025, the Board of Directors of Fortive Corporation (the “Company”) appointed Mark D. Okerstrom as Senior Vice President and Chief Financial Officer of the Company, effective March 24, 2025
Mr. Okerstrom will succeed Charles E. McLaughlin, who will retire from his role as Senior Vice President and Chief Financial Officer of the Company on the Effective Date and will continue to serve in a non-executive officer role with the Company through December 31, 2025 to assist with the transition.
Effective February 26, 2025, the Board of Directors of Fortive Corporation (the “Company”) increased the size of the Company’s Board from nine to ten members and appointed Gregory J. Moore, M.D., Ph.D., to the Board
effective January 28, 2025, the Board appointed Sharmistha Dubey, an independent director of the Company, as the Chair of the Board to succeed Mr. Spoon.
effective January 28, 2025, the Board appointed Sharmistha Dubey, an independent director of the Company, as the Chair of the Board to succeed Mr. Spoon.
On January 28, 2025, Alan G. Spoon notified the Board of Directors (the “Board”) of Fortive Corporation (the “Company”) that he has elected not to stand for re-election as a director at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”) to be held on June 3, 2025, and will retire from the Board effective on the date of the Annual Meeting.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
In addition, on August 30, 2024, Charles E. McLaughlin notified the Company of his decision to retire as Senior Vice President and Chief Financial Officer of the Company by the end of the first quarter of 2025.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
On April 24, 2023, Patrick Murphy, the President and CEO of the Advanced Healthcare Solutions segment, notified the Company that he will retire from the Company by December 31, 2023, with transition from his current position effective July 1, 2023.
Effective July 1, 2023, Tamara S. Newcombe, who is currently the President and CEO of the Precision Technologies segment of the Company, will expand her leadership responsibilities to include the Advanced Healthcare Solutions segment as the President and CEO of the Precision Technologies and Advanced Healthcare Solutions segments.
appointed Eric Branderiz to the Board with a term commencing on January 1, 2023 and expiring at the 2023 Annual Meeting of Shareholders
Max materiality 0.85 · Median 0.60 · Most common event earnings